The Joys and Woes of Clinical Trial Startup | Page 12

References »
1. CenterWatch. Survey of Investigative Sites in the US; 2009.
2.  hin R and Safar L. Clinical Trials Go Global: Next Stop, Latin America.
C
Pharma. July/August 2009.
3.  lickman SW, McHutchison JG, Peterson ED, et al. Ethical and Scientific
G
Implications of the Globalization of Clinical Research. N Engl J Med.
2009;360:816-823.
4.  eiger BJ. Managing a Successful Clinical Trial in Latin America. What Every
G
Sponsor Needs to Know. Monitor. October 2010:27-59.
5.  ood and Drug Administration. How Drugs are Developed and
F
Approved. http://www.fda.gov/drugs/developmentapprovalprocess/
howdrugsaredevelopedandapproved/default.html. Accessed September 27, 2012.
6.  hasse A. Site Metrics for Study Start Up: Clinical Trials Transformation
C
Initiative. Presented at: DIA 2012 48th Annual Meeting, Philadelphia, PA, 24-28
June 2012.
7.  eerspink HJL, Dobre D, Hillege HL, Grobbee DE, de Zeeuw D. Does the
H

17.  uropean Organisation for Research and Treatment of Cancer. International
E
Workshop: The Need for Harmonisation of Clinical Trials Insurance in Europe.
June 28, 2010.
18.  ouisa M, Takeuchi M, Setiabudy R, Nafrialdi, Takeuchi M. Current status of
L
phase I clinical trials in Asia: an academic perspective. Acta Med Indones.
2012;44:71-77.
19. Parexel Consulting. Paraxel Biopharmaceutical R&D Statistical Sourcebook, 2012/2013.
20.  eoHive. The Population of Continents, Regions and Countries. http://www.
G
geohive.com/earth/pop_region.aspx. Accessed September 30, 2012.
21.  linStar. Press Release: ClinStar to Present at Outsourcing in Clinical Trials
C
Europe. May 1, 2012.
22.  ievas OR and Schefler SG. Trials in Latin America. Applied Clinical Trials. July
N
2010:2-6.
23.  ibbink K. Olá Brazil: Latin America’s Biggest Market Accelerates.
R
PharmaVoice. January 2011:50-52.

European Clinical Trial Directive Really Improve Clinical Trial Approval Time?
Br J Clin Pharamacol. 2008;66:546-550.
8.  tate Institute for Drug Control (SUKL). KLH-20 version 5. http://www.sukl.eu/
S
medicines/klh-20-version-5. Accessed February 18, 2013.
9.  irective 2001/20/EC of the European Parliament and of the Council. http://
D
www.eortc.be/services/doc/clinical-eu-directive-04-april-01.pdf. Accessed
February 18, 2013.
10.  linical Trials in Poland. http://phamos.cz/countries/poland.htm. Accessed
C
February 18, 2013.
11.  torozhuk E, Khabriev RU, Filunin SV. International Clinical Trials in Russia:
S
An Insider’s Perspective. Monitor. February 2007:35-39.
12.  iedzielska DL and Kandalov M. Russian Rewards. International Clinical
N
Trials. Autumn 2010.
13.  zivinsky L, Koenig R. Study Start-up: A Comparison Across Emerging Markets.
D
Xtalks. September 13, 2012.
14.  eltas Clinical Research. Resources. http://www.beltas.com/faqs_resources.
B
html#1. Accessed September 27, 2012.
15.  riceWaterhouseCoopers. The Changing Dynamics of Pharma Outsourcing in Asia:
P
Are You Readjusting Your Sights? http://www.pwc.be/en/pharma/The-changingdynamics-of-pharma-outsourcing-in-Asia.pdf. Accessed March 11, 2012.
16. Wong E. Clinical Trials in Southeast Asia: An Update. Drug Inf J. 2009;43:57-61.

clinipace.com

11